Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 885 | 605 | 3,173 |
| Receivables | 1,032 | 1,089 | 1,043 |
| TOTAL | $2,020 | $1,816 | $4,312 |
| Non-Current Assets | |||
| PPE Net | 495 | 320 | 334 |
| TOTAL | $495 | $320 | $334 |
| Total Assets | $2,515 | $2,136 | $4,646 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 8,902 | 2,781 | N/A |
| Accrued Expenses | 1,831 | 1,525 | 575 |
| Other current liabilities | 1,265 | 1,213 | N/A |
| TOTAL | $15,821 | $10,532 | $581 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 719 | 276 | 693 |
| TOTAL | $574 | $0 | $4 |
| Total Liabilities | $16,395 | $10,532 | $585 |
| Shareholders' Equity | |||
| Common Shares | 18,027 | 17,289 | 18,757 |
| Retained earnings | -36,133 | -29,385 | -15,991 |
| TOTAL | $-13,543 | $-8,120 | $4,754 |
| Total Liabilities And Equity | $2,852 | $2,412 | $5,339 |